Dr Manel Vera Nefrograveleg Consultor-1 Unitat de Diagravelisi Peritoneal Seccioacute de Diagravelisi Servei de Nefrologia i Trasplantament Renal Hospital Cliacutenic de Barcelona mveracliniccat
Peculiaritats de la diagravelisi peritoneal en les malalties renals hereditagraveries
2
Malalties hereditagraveries amb afectacioacute de la MBG Siacutendrome drsquoAlport Hematuria familiar Siacutendrome ungla-rogravetula
Malalties hereditagraveries per trastorns metabogravelics amb afectacioacute renal
Malatia de Fabry Malaltia de Von Gierke Deficiegravencia familiar de lecitin-colesterol aciltransferasa Malaltia de Gaucher Malaltia de Refsum
Malalties hereditagraveries quiacutestiques del ronyoacute Poliquistosi renal autosogravemica dominant Poliquistosi renal autosogravemica recessiva Esclerosi tuberosa
40 autosogravemica dominant
Malaltia renal quiacutestica medular Nefropaties quiacutestiques hereditagraveries recesives amb malformacions muacuteltiples Nefropaties quiacutestiques hereditagraveries dominants amb malformacions muacuteltiples
Adaptat de Nefrologiacutea Cliacutenica 3ordm Edicioacute LHernando Avedantildeo Editorial Meacutedica panamericana2009
3
Poliquistosi Renal
Esclerosis Tuberosa
4
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
5
Tenen alguna peculiaritats els
pacients amb poliquistosi renal quan
estan en diagravelisi peritoneal
6
Eacutes una bona opcioacute la DP per aquests pacients
Resultats Complicacions Guioacute de la xerrada
7
There is a general perception that patients with polycystic kidney disease on peritoneal dialysis have poor long-term technique survivalhellip
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
poblacioacute jove menys comorbidahellip
Adaptat del GADDPE
8
COMPLICACIONS DE LA PARET ABDOMINAL
Causa increment de la pressioacute intraabdominal Anomalies primagraveries del colagravegen iquest
9
Soacuten gaire meacutes frequumlents en els pacients que fan DP 45 65 Podem evitar-les Suposa una causa important de fracagraves de la tegravecnica
10
142 pacients (HEgraveRNIES) 22 hegravernies umbilicals 10 incisionals 4 inguinals 3 pericategraveter
142 pacients (FUGUES) 17 fugues pericategraveter 4 inguinals 3 desconegut 53 meacutes drsquoun episodi
En 5 anys pacients consecutius mateixa unitat Mateix megravetode drsquoinsercioacute del categraveter puncioacute Mateix tipus de categraveter Temps drsquoespera per iniciar DP 3-4 setmanes
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
11
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
12
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
13
Ratio hegravernies CAPD gt APD (008 vs 001 hegraverniespacientany ns )
Necessitat de transferegravencia CAPD a DPA 49
30 pacients amb hegravernia 26 amb fuga Volums de 2 L
2
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
14
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Una peculiaritat del pacient amb PQRhellip
15
Nefrologia 201333(2)275-7 doi 103265Nefrologiapre2012Jul11646 Genital leakage associated with patent peritoneovaginal duct and polycystic kidney and liver disease in patients on peritoneal dialysis Torregrosa-de Juan E Royo-Maicas P Fernaacutendez-Naacutejera E Olaguumle-Diacuteaz P Garciacutea-Maset R Molina R Pallardo Y Saacutenchez-Canel J Garciacutea-Peacuterez H
PQR i problemes de la paretldquocheck-listrdquo Exploracioacute fiacutesica exhaustiva abans drsquo iniciar diagravelisi
peritoneal Moltes soacuten assimptomagravetiques
Reparacioacute simultagravenia amb la collocacioacute del categraveter Quan apareixenhellip
cal ser agressiu i no demorar la seva reparacioacute
Importagravencia de la insercioacute del categraveter (fugues pericategraveter ++ i hegravernies) Cal ser curoacutes amb la tegravecnica drsquoinsercioacute
Assegurar la correcta posicioacute del cuff intern a nivell del recte anterioraponeurosis (aconsellable 2 cuff)
Per evitar incrementar PIP DPA precoccedil (opinioacute personal)
16
Peritonitishellip
17
Perquegrave nrsquohi hauria drsquohaver meacutes
Intraperitoneal pressure in PD patients relationship to intraperitoneal volume body size and PD-relatedcomplications Dejardin A1 Robert A Goffin E Nephrol Dial Transplant 2007 May22(5)1437-44 Epub 2007 Feb 17
Flora de la pell fugues hegravernies Enterobactegraveries diverticles traslocacioacute bacteriana per PIP gt14 cm H20
Peritonitishellip
18
Perit Dial Int 2004 Jan-Feb24(1)79-81 A comparison of peritonitis in polycystic and non-polycystic patients on peritoneal dialysis Pandya BK1 Friede T Williams JD
Peritonitishellip
19
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
20
Germens diferents NO diferegravencies entre PQR i no PQR
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 E
Peritonitishellip
21
No diferegravencies entre el grup de PQR i no PQR
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
22
PQR Control p
Peritonitis 055 056 078
Peritonitis per enterobacteries
128 116 09
Infeccioacute de quist
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Gegravermens diferents NO diferegravencies entre PQR i no PQR
Peritonitishellip
23
No diferegravencies en la retirada de categraveter per peritonitis
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
24
PQR i peritonitisldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
25
ADEQUACIOacute
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
26
ADEQUACIOacute PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
27
PQR i adequacioacute de diagravelisildquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
28
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
2
Malalties hereditagraveries amb afectacioacute de la MBG Siacutendrome drsquoAlport Hematuria familiar Siacutendrome ungla-rogravetula
Malalties hereditagraveries per trastorns metabogravelics amb afectacioacute renal
Malatia de Fabry Malaltia de Von Gierke Deficiegravencia familiar de lecitin-colesterol aciltransferasa Malaltia de Gaucher Malaltia de Refsum
Malalties hereditagraveries quiacutestiques del ronyoacute Poliquistosi renal autosogravemica dominant Poliquistosi renal autosogravemica recessiva Esclerosi tuberosa
40 autosogravemica dominant
Malaltia renal quiacutestica medular Nefropaties quiacutestiques hereditagraveries recesives amb malformacions muacuteltiples Nefropaties quiacutestiques hereditagraveries dominants amb malformacions muacuteltiples
Adaptat de Nefrologiacutea Cliacutenica 3ordm Edicioacute LHernando Avedantildeo Editorial Meacutedica panamericana2009
3
Poliquistosi Renal
Esclerosis Tuberosa
4
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
5
Tenen alguna peculiaritats els
pacients amb poliquistosi renal quan
estan en diagravelisi peritoneal
6
Eacutes una bona opcioacute la DP per aquests pacients
Resultats Complicacions Guioacute de la xerrada
7
There is a general perception that patients with polycystic kidney disease on peritoneal dialysis have poor long-term technique survivalhellip
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
poblacioacute jove menys comorbidahellip
Adaptat del GADDPE
8
COMPLICACIONS DE LA PARET ABDOMINAL
Causa increment de la pressioacute intraabdominal Anomalies primagraveries del colagravegen iquest
9
Soacuten gaire meacutes frequumlents en els pacients que fan DP 45 65 Podem evitar-les Suposa una causa important de fracagraves de la tegravecnica
10
142 pacients (HEgraveRNIES) 22 hegravernies umbilicals 10 incisionals 4 inguinals 3 pericategraveter
142 pacients (FUGUES) 17 fugues pericategraveter 4 inguinals 3 desconegut 53 meacutes drsquoun episodi
En 5 anys pacients consecutius mateixa unitat Mateix megravetode drsquoinsercioacute del categraveter puncioacute Mateix tipus de categraveter Temps drsquoespera per iniciar DP 3-4 setmanes
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
11
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
12
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
13
Ratio hegravernies CAPD gt APD (008 vs 001 hegraverniespacientany ns )
Necessitat de transferegravencia CAPD a DPA 49
30 pacients amb hegravernia 26 amb fuga Volums de 2 L
2
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
14
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Una peculiaritat del pacient amb PQRhellip
15
Nefrologia 201333(2)275-7 doi 103265Nefrologiapre2012Jul11646 Genital leakage associated with patent peritoneovaginal duct and polycystic kidney and liver disease in patients on peritoneal dialysis Torregrosa-de Juan E Royo-Maicas P Fernaacutendez-Naacutejera E Olaguumle-Diacuteaz P Garciacutea-Maset R Molina R Pallardo Y Saacutenchez-Canel J Garciacutea-Peacuterez H
PQR i problemes de la paretldquocheck-listrdquo Exploracioacute fiacutesica exhaustiva abans drsquo iniciar diagravelisi
peritoneal Moltes soacuten assimptomagravetiques
Reparacioacute simultagravenia amb la collocacioacute del categraveter Quan apareixenhellip
cal ser agressiu i no demorar la seva reparacioacute
Importagravencia de la insercioacute del categraveter (fugues pericategraveter ++ i hegravernies) Cal ser curoacutes amb la tegravecnica drsquoinsercioacute
Assegurar la correcta posicioacute del cuff intern a nivell del recte anterioraponeurosis (aconsellable 2 cuff)
Per evitar incrementar PIP DPA precoccedil (opinioacute personal)
16
Peritonitishellip
17
Perquegrave nrsquohi hauria drsquohaver meacutes
Intraperitoneal pressure in PD patients relationship to intraperitoneal volume body size and PD-relatedcomplications Dejardin A1 Robert A Goffin E Nephrol Dial Transplant 2007 May22(5)1437-44 Epub 2007 Feb 17
Flora de la pell fugues hegravernies Enterobactegraveries diverticles traslocacioacute bacteriana per PIP gt14 cm H20
Peritonitishellip
18
Perit Dial Int 2004 Jan-Feb24(1)79-81 A comparison of peritonitis in polycystic and non-polycystic patients on peritoneal dialysis Pandya BK1 Friede T Williams JD
Peritonitishellip
19
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
20
Germens diferents NO diferegravencies entre PQR i no PQR
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 E
Peritonitishellip
21
No diferegravencies entre el grup de PQR i no PQR
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
22
PQR Control p
Peritonitis 055 056 078
Peritonitis per enterobacteries
128 116 09
Infeccioacute de quist
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Gegravermens diferents NO diferegravencies entre PQR i no PQR
Peritonitishellip
23
No diferegravencies en la retirada de categraveter per peritonitis
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
24
PQR i peritonitisldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
25
ADEQUACIOacute
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
26
ADEQUACIOacute PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
27
PQR i adequacioacute de diagravelisildquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
28
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
3
Poliquistosi Renal
Esclerosis Tuberosa
4
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
5
Tenen alguna peculiaritats els
pacients amb poliquistosi renal quan
estan en diagravelisi peritoneal
6
Eacutes una bona opcioacute la DP per aquests pacients
Resultats Complicacions Guioacute de la xerrada
7
There is a general perception that patients with polycystic kidney disease on peritoneal dialysis have poor long-term technique survivalhellip
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
poblacioacute jove menys comorbidahellip
Adaptat del GADDPE
8
COMPLICACIONS DE LA PARET ABDOMINAL
Causa increment de la pressioacute intraabdominal Anomalies primagraveries del colagravegen iquest
9
Soacuten gaire meacutes frequumlents en els pacients que fan DP 45 65 Podem evitar-les Suposa una causa important de fracagraves de la tegravecnica
10
142 pacients (HEgraveRNIES) 22 hegravernies umbilicals 10 incisionals 4 inguinals 3 pericategraveter
142 pacients (FUGUES) 17 fugues pericategraveter 4 inguinals 3 desconegut 53 meacutes drsquoun episodi
En 5 anys pacients consecutius mateixa unitat Mateix megravetode drsquoinsercioacute del categraveter puncioacute Mateix tipus de categraveter Temps drsquoespera per iniciar DP 3-4 setmanes
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
11
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
12
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
13
Ratio hegravernies CAPD gt APD (008 vs 001 hegraverniespacientany ns )
Necessitat de transferegravencia CAPD a DPA 49
30 pacients amb hegravernia 26 amb fuga Volums de 2 L
2
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
14
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Una peculiaritat del pacient amb PQRhellip
15
Nefrologia 201333(2)275-7 doi 103265Nefrologiapre2012Jul11646 Genital leakage associated with patent peritoneovaginal duct and polycystic kidney and liver disease in patients on peritoneal dialysis Torregrosa-de Juan E Royo-Maicas P Fernaacutendez-Naacutejera E Olaguumle-Diacuteaz P Garciacutea-Maset R Molina R Pallardo Y Saacutenchez-Canel J Garciacutea-Peacuterez H
PQR i problemes de la paretldquocheck-listrdquo Exploracioacute fiacutesica exhaustiva abans drsquo iniciar diagravelisi
peritoneal Moltes soacuten assimptomagravetiques
Reparacioacute simultagravenia amb la collocacioacute del categraveter Quan apareixenhellip
cal ser agressiu i no demorar la seva reparacioacute
Importagravencia de la insercioacute del categraveter (fugues pericategraveter ++ i hegravernies) Cal ser curoacutes amb la tegravecnica drsquoinsercioacute
Assegurar la correcta posicioacute del cuff intern a nivell del recte anterioraponeurosis (aconsellable 2 cuff)
Per evitar incrementar PIP DPA precoccedil (opinioacute personal)
16
Peritonitishellip
17
Perquegrave nrsquohi hauria drsquohaver meacutes
Intraperitoneal pressure in PD patients relationship to intraperitoneal volume body size and PD-relatedcomplications Dejardin A1 Robert A Goffin E Nephrol Dial Transplant 2007 May22(5)1437-44 Epub 2007 Feb 17
Flora de la pell fugues hegravernies Enterobactegraveries diverticles traslocacioacute bacteriana per PIP gt14 cm H20
Peritonitishellip
18
Perit Dial Int 2004 Jan-Feb24(1)79-81 A comparison of peritonitis in polycystic and non-polycystic patients on peritoneal dialysis Pandya BK1 Friede T Williams JD
Peritonitishellip
19
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
20
Germens diferents NO diferegravencies entre PQR i no PQR
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 E
Peritonitishellip
21
No diferegravencies entre el grup de PQR i no PQR
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
22
PQR Control p
Peritonitis 055 056 078
Peritonitis per enterobacteries
128 116 09
Infeccioacute de quist
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Gegravermens diferents NO diferegravencies entre PQR i no PQR
Peritonitishellip
23
No diferegravencies en la retirada de categraveter per peritonitis
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
24
PQR i peritonitisldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
25
ADEQUACIOacute
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
26
ADEQUACIOacute PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
27
PQR i adequacioacute de diagravelisildquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
28
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
4
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
5
Tenen alguna peculiaritats els
pacients amb poliquistosi renal quan
estan en diagravelisi peritoneal
6
Eacutes una bona opcioacute la DP per aquests pacients
Resultats Complicacions Guioacute de la xerrada
7
There is a general perception that patients with polycystic kidney disease on peritoneal dialysis have poor long-term technique survivalhellip
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
poblacioacute jove menys comorbidahellip
Adaptat del GADDPE
8
COMPLICACIONS DE LA PARET ABDOMINAL
Causa increment de la pressioacute intraabdominal Anomalies primagraveries del colagravegen iquest
9
Soacuten gaire meacutes frequumlents en els pacients que fan DP 45 65 Podem evitar-les Suposa una causa important de fracagraves de la tegravecnica
10
142 pacients (HEgraveRNIES) 22 hegravernies umbilicals 10 incisionals 4 inguinals 3 pericategraveter
142 pacients (FUGUES) 17 fugues pericategraveter 4 inguinals 3 desconegut 53 meacutes drsquoun episodi
En 5 anys pacients consecutius mateixa unitat Mateix megravetode drsquoinsercioacute del categraveter puncioacute Mateix tipus de categraveter Temps drsquoespera per iniciar DP 3-4 setmanes
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
11
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
12
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
13
Ratio hegravernies CAPD gt APD (008 vs 001 hegraverniespacientany ns )
Necessitat de transferegravencia CAPD a DPA 49
30 pacients amb hegravernia 26 amb fuga Volums de 2 L
2
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
14
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Una peculiaritat del pacient amb PQRhellip
15
Nefrologia 201333(2)275-7 doi 103265Nefrologiapre2012Jul11646 Genital leakage associated with patent peritoneovaginal duct and polycystic kidney and liver disease in patients on peritoneal dialysis Torregrosa-de Juan E Royo-Maicas P Fernaacutendez-Naacutejera E Olaguumle-Diacuteaz P Garciacutea-Maset R Molina R Pallardo Y Saacutenchez-Canel J Garciacutea-Peacuterez H
PQR i problemes de la paretldquocheck-listrdquo Exploracioacute fiacutesica exhaustiva abans drsquo iniciar diagravelisi
peritoneal Moltes soacuten assimptomagravetiques
Reparacioacute simultagravenia amb la collocacioacute del categraveter Quan apareixenhellip
cal ser agressiu i no demorar la seva reparacioacute
Importagravencia de la insercioacute del categraveter (fugues pericategraveter ++ i hegravernies) Cal ser curoacutes amb la tegravecnica drsquoinsercioacute
Assegurar la correcta posicioacute del cuff intern a nivell del recte anterioraponeurosis (aconsellable 2 cuff)
Per evitar incrementar PIP DPA precoccedil (opinioacute personal)
16
Peritonitishellip
17
Perquegrave nrsquohi hauria drsquohaver meacutes
Intraperitoneal pressure in PD patients relationship to intraperitoneal volume body size and PD-relatedcomplications Dejardin A1 Robert A Goffin E Nephrol Dial Transplant 2007 May22(5)1437-44 Epub 2007 Feb 17
Flora de la pell fugues hegravernies Enterobactegraveries diverticles traslocacioacute bacteriana per PIP gt14 cm H20
Peritonitishellip
18
Perit Dial Int 2004 Jan-Feb24(1)79-81 A comparison of peritonitis in polycystic and non-polycystic patients on peritoneal dialysis Pandya BK1 Friede T Williams JD
Peritonitishellip
19
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
20
Germens diferents NO diferegravencies entre PQR i no PQR
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 E
Peritonitishellip
21
No diferegravencies entre el grup de PQR i no PQR
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
22
PQR Control p
Peritonitis 055 056 078
Peritonitis per enterobacteries
128 116 09
Infeccioacute de quist
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Gegravermens diferents NO diferegravencies entre PQR i no PQR
Peritonitishellip
23
No diferegravencies en la retirada de categraveter per peritonitis
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
24
PQR i peritonitisldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
25
ADEQUACIOacute
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
26
ADEQUACIOacute PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
27
PQR i adequacioacute de diagravelisildquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
28
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
5
Tenen alguna peculiaritats els
pacients amb poliquistosi renal quan
estan en diagravelisi peritoneal
6
Eacutes una bona opcioacute la DP per aquests pacients
Resultats Complicacions Guioacute de la xerrada
7
There is a general perception that patients with polycystic kidney disease on peritoneal dialysis have poor long-term technique survivalhellip
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
poblacioacute jove menys comorbidahellip
Adaptat del GADDPE
8
COMPLICACIONS DE LA PARET ABDOMINAL
Causa increment de la pressioacute intraabdominal Anomalies primagraveries del colagravegen iquest
9
Soacuten gaire meacutes frequumlents en els pacients que fan DP 45 65 Podem evitar-les Suposa una causa important de fracagraves de la tegravecnica
10
142 pacients (HEgraveRNIES) 22 hegravernies umbilicals 10 incisionals 4 inguinals 3 pericategraveter
142 pacients (FUGUES) 17 fugues pericategraveter 4 inguinals 3 desconegut 53 meacutes drsquoun episodi
En 5 anys pacients consecutius mateixa unitat Mateix megravetode drsquoinsercioacute del categraveter puncioacute Mateix tipus de categraveter Temps drsquoespera per iniciar DP 3-4 setmanes
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
11
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
12
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
13
Ratio hegravernies CAPD gt APD (008 vs 001 hegraverniespacientany ns )
Necessitat de transferegravencia CAPD a DPA 49
30 pacients amb hegravernia 26 amb fuga Volums de 2 L
2
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
14
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Una peculiaritat del pacient amb PQRhellip
15
Nefrologia 201333(2)275-7 doi 103265Nefrologiapre2012Jul11646 Genital leakage associated with patent peritoneovaginal duct and polycystic kidney and liver disease in patients on peritoneal dialysis Torregrosa-de Juan E Royo-Maicas P Fernaacutendez-Naacutejera E Olaguumle-Diacuteaz P Garciacutea-Maset R Molina R Pallardo Y Saacutenchez-Canel J Garciacutea-Peacuterez H
PQR i problemes de la paretldquocheck-listrdquo Exploracioacute fiacutesica exhaustiva abans drsquo iniciar diagravelisi
peritoneal Moltes soacuten assimptomagravetiques
Reparacioacute simultagravenia amb la collocacioacute del categraveter Quan apareixenhellip
cal ser agressiu i no demorar la seva reparacioacute
Importagravencia de la insercioacute del categraveter (fugues pericategraveter ++ i hegravernies) Cal ser curoacutes amb la tegravecnica drsquoinsercioacute
Assegurar la correcta posicioacute del cuff intern a nivell del recte anterioraponeurosis (aconsellable 2 cuff)
Per evitar incrementar PIP DPA precoccedil (opinioacute personal)
16
Peritonitishellip
17
Perquegrave nrsquohi hauria drsquohaver meacutes
Intraperitoneal pressure in PD patients relationship to intraperitoneal volume body size and PD-relatedcomplications Dejardin A1 Robert A Goffin E Nephrol Dial Transplant 2007 May22(5)1437-44 Epub 2007 Feb 17
Flora de la pell fugues hegravernies Enterobactegraveries diverticles traslocacioacute bacteriana per PIP gt14 cm H20
Peritonitishellip
18
Perit Dial Int 2004 Jan-Feb24(1)79-81 A comparison of peritonitis in polycystic and non-polycystic patients on peritoneal dialysis Pandya BK1 Friede T Williams JD
Peritonitishellip
19
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
20
Germens diferents NO diferegravencies entre PQR i no PQR
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 E
Peritonitishellip
21
No diferegravencies entre el grup de PQR i no PQR
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
22
PQR Control p
Peritonitis 055 056 078
Peritonitis per enterobacteries
128 116 09
Infeccioacute de quist
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Gegravermens diferents NO diferegravencies entre PQR i no PQR
Peritonitishellip
23
No diferegravencies en la retirada de categraveter per peritonitis
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
24
PQR i peritonitisldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
25
ADEQUACIOacute
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
26
ADEQUACIOacute PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
27
PQR i adequacioacute de diagravelisildquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
28
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
Tenen alguna peculiaritats els
pacients amb poliquistosi renal quan
estan en diagravelisi peritoneal
6
Eacutes una bona opcioacute la DP per aquests pacients
Resultats Complicacions Guioacute de la xerrada
7
There is a general perception that patients with polycystic kidney disease on peritoneal dialysis have poor long-term technique survivalhellip
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
poblacioacute jove menys comorbidahellip
Adaptat del GADDPE
8
COMPLICACIONS DE LA PARET ABDOMINAL
Causa increment de la pressioacute intraabdominal Anomalies primagraveries del colagravegen iquest
9
Soacuten gaire meacutes frequumlents en els pacients que fan DP 45 65 Podem evitar-les Suposa una causa important de fracagraves de la tegravecnica
10
142 pacients (HEgraveRNIES) 22 hegravernies umbilicals 10 incisionals 4 inguinals 3 pericategraveter
142 pacients (FUGUES) 17 fugues pericategraveter 4 inguinals 3 desconegut 53 meacutes drsquoun episodi
En 5 anys pacients consecutius mateixa unitat Mateix megravetode drsquoinsercioacute del categraveter puncioacute Mateix tipus de categraveter Temps drsquoespera per iniciar DP 3-4 setmanes
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
11
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
12
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
13
Ratio hegravernies CAPD gt APD (008 vs 001 hegraverniespacientany ns )
Necessitat de transferegravencia CAPD a DPA 49
30 pacients amb hegravernia 26 amb fuga Volums de 2 L
2
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
14
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Una peculiaritat del pacient amb PQRhellip
15
Nefrologia 201333(2)275-7 doi 103265Nefrologiapre2012Jul11646 Genital leakage associated with patent peritoneovaginal duct and polycystic kidney and liver disease in patients on peritoneal dialysis Torregrosa-de Juan E Royo-Maicas P Fernaacutendez-Naacutejera E Olaguumle-Diacuteaz P Garciacutea-Maset R Molina R Pallardo Y Saacutenchez-Canel J Garciacutea-Peacuterez H
PQR i problemes de la paretldquocheck-listrdquo Exploracioacute fiacutesica exhaustiva abans drsquo iniciar diagravelisi
peritoneal Moltes soacuten assimptomagravetiques
Reparacioacute simultagravenia amb la collocacioacute del categraveter Quan apareixenhellip
cal ser agressiu i no demorar la seva reparacioacute
Importagravencia de la insercioacute del categraveter (fugues pericategraveter ++ i hegravernies) Cal ser curoacutes amb la tegravecnica drsquoinsercioacute
Assegurar la correcta posicioacute del cuff intern a nivell del recte anterioraponeurosis (aconsellable 2 cuff)
Per evitar incrementar PIP DPA precoccedil (opinioacute personal)
16
Peritonitishellip
17
Perquegrave nrsquohi hauria drsquohaver meacutes
Intraperitoneal pressure in PD patients relationship to intraperitoneal volume body size and PD-relatedcomplications Dejardin A1 Robert A Goffin E Nephrol Dial Transplant 2007 May22(5)1437-44 Epub 2007 Feb 17
Flora de la pell fugues hegravernies Enterobactegraveries diverticles traslocacioacute bacteriana per PIP gt14 cm H20
Peritonitishellip
18
Perit Dial Int 2004 Jan-Feb24(1)79-81 A comparison of peritonitis in polycystic and non-polycystic patients on peritoneal dialysis Pandya BK1 Friede T Williams JD
Peritonitishellip
19
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
20
Germens diferents NO diferegravencies entre PQR i no PQR
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 E
Peritonitishellip
21
No diferegravencies entre el grup de PQR i no PQR
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
22
PQR Control p
Peritonitis 055 056 078
Peritonitis per enterobacteries
128 116 09
Infeccioacute de quist
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Gegravermens diferents NO diferegravencies entre PQR i no PQR
Peritonitishellip
23
No diferegravencies en la retirada de categraveter per peritonitis
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
24
PQR i peritonitisldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
25
ADEQUACIOacute
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
26
ADEQUACIOacute PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
27
PQR i adequacioacute de diagravelisildquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
28
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
7
There is a general perception that patients with polycystic kidney disease on peritoneal dialysis have poor long-term technique survivalhellip
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
poblacioacute jove menys comorbidahellip
Adaptat del GADDPE
8
COMPLICACIONS DE LA PARET ABDOMINAL
Causa increment de la pressioacute intraabdominal Anomalies primagraveries del colagravegen iquest
9
Soacuten gaire meacutes frequumlents en els pacients que fan DP 45 65 Podem evitar-les Suposa una causa important de fracagraves de la tegravecnica
10
142 pacients (HEgraveRNIES) 22 hegravernies umbilicals 10 incisionals 4 inguinals 3 pericategraveter
142 pacients (FUGUES) 17 fugues pericategraveter 4 inguinals 3 desconegut 53 meacutes drsquoun episodi
En 5 anys pacients consecutius mateixa unitat Mateix megravetode drsquoinsercioacute del categraveter puncioacute Mateix tipus de categraveter Temps drsquoespera per iniciar DP 3-4 setmanes
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
11
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
12
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
13
Ratio hegravernies CAPD gt APD (008 vs 001 hegraverniespacientany ns )
Necessitat de transferegravencia CAPD a DPA 49
30 pacients amb hegravernia 26 amb fuga Volums de 2 L
2
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
14
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Una peculiaritat del pacient amb PQRhellip
15
Nefrologia 201333(2)275-7 doi 103265Nefrologiapre2012Jul11646 Genital leakage associated with patent peritoneovaginal duct and polycystic kidney and liver disease in patients on peritoneal dialysis Torregrosa-de Juan E Royo-Maicas P Fernaacutendez-Naacutejera E Olaguumle-Diacuteaz P Garciacutea-Maset R Molina R Pallardo Y Saacutenchez-Canel J Garciacutea-Peacuterez H
PQR i problemes de la paretldquocheck-listrdquo Exploracioacute fiacutesica exhaustiva abans drsquo iniciar diagravelisi
peritoneal Moltes soacuten assimptomagravetiques
Reparacioacute simultagravenia amb la collocacioacute del categraveter Quan apareixenhellip
cal ser agressiu i no demorar la seva reparacioacute
Importagravencia de la insercioacute del categraveter (fugues pericategraveter ++ i hegravernies) Cal ser curoacutes amb la tegravecnica drsquoinsercioacute
Assegurar la correcta posicioacute del cuff intern a nivell del recte anterioraponeurosis (aconsellable 2 cuff)
Per evitar incrementar PIP DPA precoccedil (opinioacute personal)
16
Peritonitishellip
17
Perquegrave nrsquohi hauria drsquohaver meacutes
Intraperitoneal pressure in PD patients relationship to intraperitoneal volume body size and PD-relatedcomplications Dejardin A1 Robert A Goffin E Nephrol Dial Transplant 2007 May22(5)1437-44 Epub 2007 Feb 17
Flora de la pell fugues hegravernies Enterobactegraveries diverticles traslocacioacute bacteriana per PIP gt14 cm H20
Peritonitishellip
18
Perit Dial Int 2004 Jan-Feb24(1)79-81 A comparison of peritonitis in polycystic and non-polycystic patients on peritoneal dialysis Pandya BK1 Friede T Williams JD
Peritonitishellip
19
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
20
Germens diferents NO diferegravencies entre PQR i no PQR
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 E
Peritonitishellip
21
No diferegravencies entre el grup de PQR i no PQR
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
22
PQR Control p
Peritonitis 055 056 078
Peritonitis per enterobacteries
128 116 09
Infeccioacute de quist
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Gegravermens diferents NO diferegravencies entre PQR i no PQR
Peritonitishellip
23
No diferegravencies en la retirada de categraveter per peritonitis
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
24
PQR i peritonitisldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
25
ADEQUACIOacute
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
26
ADEQUACIOacute PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
27
PQR i adequacioacute de diagravelisildquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
28
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
poblacioacute jove menys comorbidahellip
Adaptat del GADDPE
8
COMPLICACIONS DE LA PARET ABDOMINAL
Causa increment de la pressioacute intraabdominal Anomalies primagraveries del colagravegen iquest
9
Soacuten gaire meacutes frequumlents en els pacients que fan DP 45 65 Podem evitar-les Suposa una causa important de fracagraves de la tegravecnica
10
142 pacients (HEgraveRNIES) 22 hegravernies umbilicals 10 incisionals 4 inguinals 3 pericategraveter
142 pacients (FUGUES) 17 fugues pericategraveter 4 inguinals 3 desconegut 53 meacutes drsquoun episodi
En 5 anys pacients consecutius mateixa unitat Mateix megravetode drsquoinsercioacute del categraveter puncioacute Mateix tipus de categraveter Temps drsquoespera per iniciar DP 3-4 setmanes
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
11
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
12
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
13
Ratio hegravernies CAPD gt APD (008 vs 001 hegraverniespacientany ns )
Necessitat de transferegravencia CAPD a DPA 49
30 pacients amb hegravernia 26 amb fuga Volums de 2 L
2
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
14
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Una peculiaritat del pacient amb PQRhellip
15
Nefrologia 201333(2)275-7 doi 103265Nefrologiapre2012Jul11646 Genital leakage associated with patent peritoneovaginal duct and polycystic kidney and liver disease in patients on peritoneal dialysis Torregrosa-de Juan E Royo-Maicas P Fernaacutendez-Naacutejera E Olaguumle-Diacuteaz P Garciacutea-Maset R Molina R Pallardo Y Saacutenchez-Canel J Garciacutea-Peacuterez H
PQR i problemes de la paretldquocheck-listrdquo Exploracioacute fiacutesica exhaustiva abans drsquo iniciar diagravelisi
peritoneal Moltes soacuten assimptomagravetiques
Reparacioacute simultagravenia amb la collocacioacute del categraveter Quan apareixenhellip
cal ser agressiu i no demorar la seva reparacioacute
Importagravencia de la insercioacute del categraveter (fugues pericategraveter ++ i hegravernies) Cal ser curoacutes amb la tegravecnica drsquoinsercioacute
Assegurar la correcta posicioacute del cuff intern a nivell del recte anterioraponeurosis (aconsellable 2 cuff)
Per evitar incrementar PIP DPA precoccedil (opinioacute personal)
16
Peritonitishellip
17
Perquegrave nrsquohi hauria drsquohaver meacutes
Intraperitoneal pressure in PD patients relationship to intraperitoneal volume body size and PD-relatedcomplications Dejardin A1 Robert A Goffin E Nephrol Dial Transplant 2007 May22(5)1437-44 Epub 2007 Feb 17
Flora de la pell fugues hegravernies Enterobactegraveries diverticles traslocacioacute bacteriana per PIP gt14 cm H20
Peritonitishellip
18
Perit Dial Int 2004 Jan-Feb24(1)79-81 A comparison of peritonitis in polycystic and non-polycystic patients on peritoneal dialysis Pandya BK1 Friede T Williams JD
Peritonitishellip
19
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
20
Germens diferents NO diferegravencies entre PQR i no PQR
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 E
Peritonitishellip
21
No diferegravencies entre el grup de PQR i no PQR
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
22
PQR Control p
Peritonitis 055 056 078
Peritonitis per enterobacteries
128 116 09
Infeccioacute de quist
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Gegravermens diferents NO diferegravencies entre PQR i no PQR
Peritonitishellip
23
No diferegravencies en la retirada de categraveter per peritonitis
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
24
PQR i peritonitisldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
25
ADEQUACIOacute
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
26
ADEQUACIOacute PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
27
PQR i adequacioacute de diagravelisildquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
28
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
COMPLICACIONS DE LA PARET ABDOMINAL
Causa increment de la pressioacute intraabdominal Anomalies primagraveries del colagravegen iquest
9
Soacuten gaire meacutes frequumlents en els pacients que fan DP 45 65 Podem evitar-les Suposa una causa important de fracagraves de la tegravecnica
10
142 pacients (HEgraveRNIES) 22 hegravernies umbilicals 10 incisionals 4 inguinals 3 pericategraveter
142 pacients (FUGUES) 17 fugues pericategraveter 4 inguinals 3 desconegut 53 meacutes drsquoun episodi
En 5 anys pacients consecutius mateixa unitat Mateix megravetode drsquoinsercioacute del categraveter puncioacute Mateix tipus de categraveter Temps drsquoespera per iniciar DP 3-4 setmanes
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
11
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
12
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
13
Ratio hegravernies CAPD gt APD (008 vs 001 hegraverniespacientany ns )
Necessitat de transferegravencia CAPD a DPA 49
30 pacients amb hegravernia 26 amb fuga Volums de 2 L
2
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
14
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Una peculiaritat del pacient amb PQRhellip
15
Nefrologia 201333(2)275-7 doi 103265Nefrologiapre2012Jul11646 Genital leakage associated with patent peritoneovaginal duct and polycystic kidney and liver disease in patients on peritoneal dialysis Torregrosa-de Juan E Royo-Maicas P Fernaacutendez-Naacutejera E Olaguumle-Diacuteaz P Garciacutea-Maset R Molina R Pallardo Y Saacutenchez-Canel J Garciacutea-Peacuterez H
PQR i problemes de la paretldquocheck-listrdquo Exploracioacute fiacutesica exhaustiva abans drsquo iniciar diagravelisi
peritoneal Moltes soacuten assimptomagravetiques
Reparacioacute simultagravenia amb la collocacioacute del categraveter Quan apareixenhellip
cal ser agressiu i no demorar la seva reparacioacute
Importagravencia de la insercioacute del categraveter (fugues pericategraveter ++ i hegravernies) Cal ser curoacutes amb la tegravecnica drsquoinsercioacute
Assegurar la correcta posicioacute del cuff intern a nivell del recte anterioraponeurosis (aconsellable 2 cuff)
Per evitar incrementar PIP DPA precoccedil (opinioacute personal)
16
Peritonitishellip
17
Perquegrave nrsquohi hauria drsquohaver meacutes
Intraperitoneal pressure in PD patients relationship to intraperitoneal volume body size and PD-relatedcomplications Dejardin A1 Robert A Goffin E Nephrol Dial Transplant 2007 May22(5)1437-44 Epub 2007 Feb 17
Flora de la pell fugues hegravernies Enterobactegraveries diverticles traslocacioacute bacteriana per PIP gt14 cm H20
Peritonitishellip
18
Perit Dial Int 2004 Jan-Feb24(1)79-81 A comparison of peritonitis in polycystic and non-polycystic patients on peritoneal dialysis Pandya BK1 Friede T Williams JD
Peritonitishellip
19
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
20
Germens diferents NO diferegravencies entre PQR i no PQR
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 E
Peritonitishellip
21
No diferegravencies entre el grup de PQR i no PQR
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
22
PQR Control p
Peritonitis 055 056 078
Peritonitis per enterobacteries
128 116 09
Infeccioacute de quist
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Gegravermens diferents NO diferegravencies entre PQR i no PQR
Peritonitishellip
23
No diferegravencies en la retirada de categraveter per peritonitis
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
24
PQR i peritonitisldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
25
ADEQUACIOacute
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
26
ADEQUACIOacute PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
27
PQR i adequacioacute de diagravelisildquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
28
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
10
142 pacients (HEgraveRNIES) 22 hegravernies umbilicals 10 incisionals 4 inguinals 3 pericategraveter
142 pacients (FUGUES) 17 fugues pericategraveter 4 inguinals 3 desconegut 53 meacutes drsquoun episodi
En 5 anys pacients consecutius mateixa unitat Mateix megravetode drsquoinsercioacute del categraveter puncioacute Mateix tipus de categraveter Temps drsquoespera per iniciar DP 3-4 setmanes
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
11
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
12
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
13
Ratio hegravernies CAPD gt APD (008 vs 001 hegraverniespacientany ns )
Necessitat de transferegravencia CAPD a DPA 49
30 pacients amb hegravernia 26 amb fuga Volums de 2 L
2
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
14
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Una peculiaritat del pacient amb PQRhellip
15
Nefrologia 201333(2)275-7 doi 103265Nefrologiapre2012Jul11646 Genital leakage associated with patent peritoneovaginal duct and polycystic kidney and liver disease in patients on peritoneal dialysis Torregrosa-de Juan E Royo-Maicas P Fernaacutendez-Naacutejera E Olaguumle-Diacuteaz P Garciacutea-Maset R Molina R Pallardo Y Saacutenchez-Canel J Garciacutea-Peacuterez H
PQR i problemes de la paretldquocheck-listrdquo Exploracioacute fiacutesica exhaustiva abans drsquo iniciar diagravelisi
peritoneal Moltes soacuten assimptomagravetiques
Reparacioacute simultagravenia amb la collocacioacute del categraveter Quan apareixenhellip
cal ser agressiu i no demorar la seva reparacioacute
Importagravencia de la insercioacute del categraveter (fugues pericategraveter ++ i hegravernies) Cal ser curoacutes amb la tegravecnica drsquoinsercioacute
Assegurar la correcta posicioacute del cuff intern a nivell del recte anterioraponeurosis (aconsellable 2 cuff)
Per evitar incrementar PIP DPA precoccedil (opinioacute personal)
16
Peritonitishellip
17
Perquegrave nrsquohi hauria drsquohaver meacutes
Intraperitoneal pressure in PD patients relationship to intraperitoneal volume body size and PD-relatedcomplications Dejardin A1 Robert A Goffin E Nephrol Dial Transplant 2007 May22(5)1437-44 Epub 2007 Feb 17
Flora de la pell fugues hegravernies Enterobactegraveries diverticles traslocacioacute bacteriana per PIP gt14 cm H20
Peritonitishellip
18
Perit Dial Int 2004 Jan-Feb24(1)79-81 A comparison of peritonitis in polycystic and non-polycystic patients on peritoneal dialysis Pandya BK1 Friede T Williams JD
Peritonitishellip
19
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
20
Germens diferents NO diferegravencies entre PQR i no PQR
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 E
Peritonitishellip
21
No diferegravencies entre el grup de PQR i no PQR
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
22
PQR Control p
Peritonitis 055 056 078
Peritonitis per enterobacteries
128 116 09
Infeccioacute de quist
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Gegravermens diferents NO diferegravencies entre PQR i no PQR
Peritonitishellip
23
No diferegravencies en la retirada de categraveter per peritonitis
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
24
PQR i peritonitisldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
25
ADEQUACIOacute
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
26
ADEQUACIOacute PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
27
PQR i adequacioacute de diagravelisildquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
28
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
11
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
12
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
13
Ratio hegravernies CAPD gt APD (008 vs 001 hegraverniespacientany ns )
Necessitat de transferegravencia CAPD a DPA 49
30 pacients amb hegravernia 26 amb fuga Volums de 2 L
2
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
14
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Una peculiaritat del pacient amb PQRhellip
15
Nefrologia 201333(2)275-7 doi 103265Nefrologiapre2012Jul11646 Genital leakage associated with patent peritoneovaginal duct and polycystic kidney and liver disease in patients on peritoneal dialysis Torregrosa-de Juan E Royo-Maicas P Fernaacutendez-Naacutejera E Olaguumle-Diacuteaz P Garciacutea-Maset R Molina R Pallardo Y Saacutenchez-Canel J Garciacutea-Peacuterez H
PQR i problemes de la paretldquocheck-listrdquo Exploracioacute fiacutesica exhaustiva abans drsquo iniciar diagravelisi
peritoneal Moltes soacuten assimptomagravetiques
Reparacioacute simultagravenia amb la collocacioacute del categraveter Quan apareixenhellip
cal ser agressiu i no demorar la seva reparacioacute
Importagravencia de la insercioacute del categraveter (fugues pericategraveter ++ i hegravernies) Cal ser curoacutes amb la tegravecnica drsquoinsercioacute
Assegurar la correcta posicioacute del cuff intern a nivell del recte anterioraponeurosis (aconsellable 2 cuff)
Per evitar incrementar PIP DPA precoccedil (opinioacute personal)
16
Peritonitishellip
17
Perquegrave nrsquohi hauria drsquohaver meacutes
Intraperitoneal pressure in PD patients relationship to intraperitoneal volume body size and PD-relatedcomplications Dejardin A1 Robert A Goffin E Nephrol Dial Transplant 2007 May22(5)1437-44 Epub 2007 Feb 17
Flora de la pell fugues hegravernies Enterobactegraveries diverticles traslocacioacute bacteriana per PIP gt14 cm H20
Peritonitishellip
18
Perit Dial Int 2004 Jan-Feb24(1)79-81 A comparison of peritonitis in polycystic and non-polycystic patients on peritoneal dialysis Pandya BK1 Friede T Williams JD
Peritonitishellip
19
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
20
Germens diferents NO diferegravencies entre PQR i no PQR
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 E
Peritonitishellip
21
No diferegravencies entre el grup de PQR i no PQR
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
22
PQR Control p
Peritonitis 055 056 078
Peritonitis per enterobacteries
128 116 09
Infeccioacute de quist
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Gegravermens diferents NO diferegravencies entre PQR i no PQR
Peritonitishellip
23
No diferegravencies en la retirada de categraveter per peritonitis
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
24
PQR i peritonitisldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
25
ADEQUACIOacute
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
26
ADEQUACIOacute PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
27
PQR i adequacioacute de diagravelisildquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
28
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
12
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
13
Ratio hegravernies CAPD gt APD (008 vs 001 hegraverniespacientany ns )
Necessitat de transferegravencia CAPD a DPA 49
30 pacients amb hegravernia 26 amb fuga Volums de 2 L
2
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
14
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Una peculiaritat del pacient amb PQRhellip
15
Nefrologia 201333(2)275-7 doi 103265Nefrologiapre2012Jul11646 Genital leakage associated with patent peritoneovaginal duct and polycystic kidney and liver disease in patients on peritoneal dialysis Torregrosa-de Juan E Royo-Maicas P Fernaacutendez-Naacutejera E Olaguumle-Diacuteaz P Garciacutea-Maset R Molina R Pallardo Y Saacutenchez-Canel J Garciacutea-Peacuterez H
PQR i problemes de la paretldquocheck-listrdquo Exploracioacute fiacutesica exhaustiva abans drsquo iniciar diagravelisi
peritoneal Moltes soacuten assimptomagravetiques
Reparacioacute simultagravenia amb la collocacioacute del categraveter Quan apareixenhellip
cal ser agressiu i no demorar la seva reparacioacute
Importagravencia de la insercioacute del categraveter (fugues pericategraveter ++ i hegravernies) Cal ser curoacutes amb la tegravecnica drsquoinsercioacute
Assegurar la correcta posicioacute del cuff intern a nivell del recte anterioraponeurosis (aconsellable 2 cuff)
Per evitar incrementar PIP DPA precoccedil (opinioacute personal)
16
Peritonitishellip
17
Perquegrave nrsquohi hauria drsquohaver meacutes
Intraperitoneal pressure in PD patients relationship to intraperitoneal volume body size and PD-relatedcomplications Dejardin A1 Robert A Goffin E Nephrol Dial Transplant 2007 May22(5)1437-44 Epub 2007 Feb 17
Flora de la pell fugues hegravernies Enterobactegraveries diverticles traslocacioacute bacteriana per PIP gt14 cm H20
Peritonitishellip
18
Perit Dial Int 2004 Jan-Feb24(1)79-81 A comparison of peritonitis in polycystic and non-polycystic patients on peritoneal dialysis Pandya BK1 Friede T Williams JD
Peritonitishellip
19
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
20
Germens diferents NO diferegravencies entre PQR i no PQR
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 E
Peritonitishellip
21
No diferegravencies entre el grup de PQR i no PQR
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
22
PQR Control p
Peritonitis 055 056 078
Peritonitis per enterobacteries
128 116 09
Infeccioacute de quist
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Gegravermens diferents NO diferegravencies entre PQR i no PQR
Peritonitishellip
23
No diferegravencies en la retirada de categraveter per peritonitis
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
24
PQR i peritonitisldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
25
ADEQUACIOacute
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
26
ADEQUACIOacute PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
27
PQR i adequacioacute de diagravelisildquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
28
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
13
Ratio hegravernies CAPD gt APD (008 vs 001 hegraverniespacientany ns )
Necessitat de transferegravencia CAPD a DPA 49
30 pacients amb hegravernia 26 amb fuga Volums de 2 L
2
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
14
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Una peculiaritat del pacient amb PQRhellip
15
Nefrologia 201333(2)275-7 doi 103265Nefrologiapre2012Jul11646 Genital leakage associated with patent peritoneovaginal duct and polycystic kidney and liver disease in patients on peritoneal dialysis Torregrosa-de Juan E Royo-Maicas P Fernaacutendez-Naacutejera E Olaguumle-Diacuteaz P Garciacutea-Maset R Molina R Pallardo Y Saacutenchez-Canel J Garciacutea-Peacuterez H
PQR i problemes de la paretldquocheck-listrdquo Exploracioacute fiacutesica exhaustiva abans drsquo iniciar diagravelisi
peritoneal Moltes soacuten assimptomagravetiques
Reparacioacute simultagravenia amb la collocacioacute del categraveter Quan apareixenhellip
cal ser agressiu i no demorar la seva reparacioacute
Importagravencia de la insercioacute del categraveter (fugues pericategraveter ++ i hegravernies) Cal ser curoacutes amb la tegravecnica drsquoinsercioacute
Assegurar la correcta posicioacute del cuff intern a nivell del recte anterioraponeurosis (aconsellable 2 cuff)
Per evitar incrementar PIP DPA precoccedil (opinioacute personal)
16
Peritonitishellip
17
Perquegrave nrsquohi hauria drsquohaver meacutes
Intraperitoneal pressure in PD patients relationship to intraperitoneal volume body size and PD-relatedcomplications Dejardin A1 Robert A Goffin E Nephrol Dial Transplant 2007 May22(5)1437-44 Epub 2007 Feb 17
Flora de la pell fugues hegravernies Enterobactegraveries diverticles traslocacioacute bacteriana per PIP gt14 cm H20
Peritonitishellip
18
Perit Dial Int 2004 Jan-Feb24(1)79-81 A comparison of peritonitis in polycystic and non-polycystic patients on peritoneal dialysis Pandya BK1 Friede T Williams JD
Peritonitishellip
19
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
20
Germens diferents NO diferegravencies entre PQR i no PQR
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 E
Peritonitishellip
21
No diferegravencies entre el grup de PQR i no PQR
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
22
PQR Control p
Peritonitis 055 056 078
Peritonitis per enterobacteries
128 116 09
Infeccioacute de quist
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Gegravermens diferents NO diferegravencies entre PQR i no PQR
Peritonitishellip
23
No diferegravencies en la retirada de categraveter per peritonitis
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
24
PQR i peritonitisldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
25
ADEQUACIOacute
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
26
ADEQUACIOacute PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
27
PQR i adequacioacute de diagravelisildquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
28
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
14
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Una peculiaritat del pacient amb PQRhellip
15
Nefrologia 201333(2)275-7 doi 103265Nefrologiapre2012Jul11646 Genital leakage associated with patent peritoneovaginal duct and polycystic kidney and liver disease in patients on peritoneal dialysis Torregrosa-de Juan E Royo-Maicas P Fernaacutendez-Naacutejera E Olaguumle-Diacuteaz P Garciacutea-Maset R Molina R Pallardo Y Saacutenchez-Canel J Garciacutea-Peacuterez H
PQR i problemes de la paretldquocheck-listrdquo Exploracioacute fiacutesica exhaustiva abans drsquo iniciar diagravelisi
peritoneal Moltes soacuten assimptomagravetiques
Reparacioacute simultagravenia amb la collocacioacute del categraveter Quan apareixenhellip
cal ser agressiu i no demorar la seva reparacioacute
Importagravencia de la insercioacute del categraveter (fugues pericategraveter ++ i hegravernies) Cal ser curoacutes amb la tegravecnica drsquoinsercioacute
Assegurar la correcta posicioacute del cuff intern a nivell del recte anterioraponeurosis (aconsellable 2 cuff)
Per evitar incrementar PIP DPA precoccedil (opinioacute personal)
16
Peritonitishellip
17
Perquegrave nrsquohi hauria drsquohaver meacutes
Intraperitoneal pressure in PD patients relationship to intraperitoneal volume body size and PD-relatedcomplications Dejardin A1 Robert A Goffin E Nephrol Dial Transplant 2007 May22(5)1437-44 Epub 2007 Feb 17
Flora de la pell fugues hegravernies Enterobactegraveries diverticles traslocacioacute bacteriana per PIP gt14 cm H20
Peritonitishellip
18
Perit Dial Int 2004 Jan-Feb24(1)79-81 A comparison of peritonitis in polycystic and non-polycystic patients on peritoneal dialysis Pandya BK1 Friede T Williams JD
Peritonitishellip
19
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
20
Germens diferents NO diferegravencies entre PQR i no PQR
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 E
Peritonitishellip
21
No diferegravencies entre el grup de PQR i no PQR
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
22
PQR Control p
Peritonitis 055 056 078
Peritonitis per enterobacteries
128 116 09
Infeccioacute de quist
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Gegravermens diferents NO diferegravencies entre PQR i no PQR
Peritonitishellip
23
No diferegravencies en la retirada de categraveter per peritonitis
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
24
PQR i peritonitisldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
25
ADEQUACIOacute
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
26
ADEQUACIOacute PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
27
PQR i adequacioacute de diagravelisildquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
28
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
Una peculiaritat del pacient amb PQRhellip
15
Nefrologia 201333(2)275-7 doi 103265Nefrologiapre2012Jul11646 Genital leakage associated with patent peritoneovaginal duct and polycystic kidney and liver disease in patients on peritoneal dialysis Torregrosa-de Juan E Royo-Maicas P Fernaacutendez-Naacutejera E Olaguumle-Diacuteaz P Garciacutea-Maset R Molina R Pallardo Y Saacutenchez-Canel J Garciacutea-Peacuterez H
PQR i problemes de la paretldquocheck-listrdquo Exploracioacute fiacutesica exhaustiva abans drsquo iniciar diagravelisi
peritoneal Moltes soacuten assimptomagravetiques
Reparacioacute simultagravenia amb la collocacioacute del categraveter Quan apareixenhellip
cal ser agressiu i no demorar la seva reparacioacute
Importagravencia de la insercioacute del categraveter (fugues pericategraveter ++ i hegravernies) Cal ser curoacutes amb la tegravecnica drsquoinsercioacute
Assegurar la correcta posicioacute del cuff intern a nivell del recte anterioraponeurosis (aconsellable 2 cuff)
Per evitar incrementar PIP DPA precoccedil (opinioacute personal)
16
Peritonitishellip
17
Perquegrave nrsquohi hauria drsquohaver meacutes
Intraperitoneal pressure in PD patients relationship to intraperitoneal volume body size and PD-relatedcomplications Dejardin A1 Robert A Goffin E Nephrol Dial Transplant 2007 May22(5)1437-44 Epub 2007 Feb 17
Flora de la pell fugues hegravernies Enterobactegraveries diverticles traslocacioacute bacteriana per PIP gt14 cm H20
Peritonitishellip
18
Perit Dial Int 2004 Jan-Feb24(1)79-81 A comparison of peritonitis in polycystic and non-polycystic patients on peritoneal dialysis Pandya BK1 Friede T Williams JD
Peritonitishellip
19
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
20
Germens diferents NO diferegravencies entre PQR i no PQR
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 E
Peritonitishellip
21
No diferegravencies entre el grup de PQR i no PQR
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
22
PQR Control p
Peritonitis 055 056 078
Peritonitis per enterobacteries
128 116 09
Infeccioacute de quist
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Gegravermens diferents NO diferegravencies entre PQR i no PQR
Peritonitishellip
23
No diferegravencies en la retirada de categraveter per peritonitis
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
24
PQR i peritonitisldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
25
ADEQUACIOacute
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
26
ADEQUACIOacute PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
27
PQR i adequacioacute de diagravelisildquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
28
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
PQR i problemes de la paretldquocheck-listrdquo Exploracioacute fiacutesica exhaustiva abans drsquo iniciar diagravelisi
peritoneal Moltes soacuten assimptomagravetiques
Reparacioacute simultagravenia amb la collocacioacute del categraveter Quan apareixenhellip
cal ser agressiu i no demorar la seva reparacioacute
Importagravencia de la insercioacute del categraveter (fugues pericategraveter ++ i hegravernies) Cal ser curoacutes amb la tegravecnica drsquoinsercioacute
Assegurar la correcta posicioacute del cuff intern a nivell del recte anterioraponeurosis (aconsellable 2 cuff)
Per evitar incrementar PIP DPA precoccedil (opinioacute personal)
16
Peritonitishellip
17
Perquegrave nrsquohi hauria drsquohaver meacutes
Intraperitoneal pressure in PD patients relationship to intraperitoneal volume body size and PD-relatedcomplications Dejardin A1 Robert A Goffin E Nephrol Dial Transplant 2007 May22(5)1437-44 Epub 2007 Feb 17
Flora de la pell fugues hegravernies Enterobactegraveries diverticles traslocacioacute bacteriana per PIP gt14 cm H20
Peritonitishellip
18
Perit Dial Int 2004 Jan-Feb24(1)79-81 A comparison of peritonitis in polycystic and non-polycystic patients on peritoneal dialysis Pandya BK1 Friede T Williams JD
Peritonitishellip
19
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
20
Germens diferents NO diferegravencies entre PQR i no PQR
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 E
Peritonitishellip
21
No diferegravencies entre el grup de PQR i no PQR
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
22
PQR Control p
Peritonitis 055 056 078
Peritonitis per enterobacteries
128 116 09
Infeccioacute de quist
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Gegravermens diferents NO diferegravencies entre PQR i no PQR
Peritonitishellip
23
No diferegravencies en la retirada de categraveter per peritonitis
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
24
PQR i peritonitisldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
25
ADEQUACIOacute
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
26
ADEQUACIOacute PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
27
PQR i adequacioacute de diagravelisildquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
28
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
Peritonitishellip
17
Perquegrave nrsquohi hauria drsquohaver meacutes
Intraperitoneal pressure in PD patients relationship to intraperitoneal volume body size and PD-relatedcomplications Dejardin A1 Robert A Goffin E Nephrol Dial Transplant 2007 May22(5)1437-44 Epub 2007 Feb 17
Flora de la pell fugues hegravernies Enterobactegraveries diverticles traslocacioacute bacteriana per PIP gt14 cm H20
Peritonitishellip
18
Perit Dial Int 2004 Jan-Feb24(1)79-81 A comparison of peritonitis in polycystic and non-polycystic patients on peritoneal dialysis Pandya BK1 Friede T Williams JD
Peritonitishellip
19
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
20
Germens diferents NO diferegravencies entre PQR i no PQR
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 E
Peritonitishellip
21
No diferegravencies entre el grup de PQR i no PQR
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
22
PQR Control p
Peritonitis 055 056 078
Peritonitis per enterobacteries
128 116 09
Infeccioacute de quist
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Gegravermens diferents NO diferegravencies entre PQR i no PQR
Peritonitishellip
23
No diferegravencies en la retirada de categraveter per peritonitis
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
24
PQR i peritonitisldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
25
ADEQUACIOacute
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
26
ADEQUACIOacute PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
27
PQR i adequacioacute de diagravelisildquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
28
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
Peritonitishellip
18
Perit Dial Int 2004 Jan-Feb24(1)79-81 A comparison of peritonitis in polycystic and non-polycystic patients on peritoneal dialysis Pandya BK1 Friede T Williams JD
Peritonitishellip
19
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
20
Germens diferents NO diferegravencies entre PQR i no PQR
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 E
Peritonitishellip
21
No diferegravencies entre el grup de PQR i no PQR
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
22
PQR Control p
Peritonitis 055 056 078
Peritonitis per enterobacteries
128 116 09
Infeccioacute de quist
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Gegravermens diferents NO diferegravencies entre PQR i no PQR
Peritonitishellip
23
No diferegravencies en la retirada de categraveter per peritonitis
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
24
PQR i peritonitisldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
25
ADEQUACIOacute
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
26
ADEQUACIOacute PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
27
PQR i adequacioacute de diagravelisildquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
28
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
Peritonitishellip
19
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
20
Germens diferents NO diferegravencies entre PQR i no PQR
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 E
Peritonitishellip
21
No diferegravencies entre el grup de PQR i no PQR
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
22
PQR Control p
Peritonitis 055 056 078
Peritonitis per enterobacteries
128 116 09
Infeccioacute de quist
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Gegravermens diferents NO diferegravencies entre PQR i no PQR
Peritonitishellip
23
No diferegravencies en la retirada de categraveter per peritonitis
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
24
PQR i peritonitisldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
25
ADEQUACIOacute
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
26
ADEQUACIOacute PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
27
PQR i adequacioacute de diagravelisildquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
28
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
Peritonitishellip
20
Germens diferents NO diferegravencies entre PQR i no PQR
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 E
Peritonitishellip
21
No diferegravencies entre el grup de PQR i no PQR
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
22
PQR Control p
Peritonitis 055 056 078
Peritonitis per enterobacteries
128 116 09
Infeccioacute de quist
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Gegravermens diferents NO diferegravencies entre PQR i no PQR
Peritonitishellip
23
No diferegravencies en la retirada de categraveter per peritonitis
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
24
PQR i peritonitisldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
25
ADEQUACIOacute
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
26
ADEQUACIOacute PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
27
PQR i adequacioacute de diagravelisildquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
28
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
Peritonitishellip
21
No diferegravencies entre el grup de PQR i no PQR
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Peritonitishellip
22
PQR Control p
Peritonitis 055 056 078
Peritonitis per enterobacteries
128 116 09
Infeccioacute de quist
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Gegravermens diferents NO diferegravencies entre PQR i no PQR
Peritonitishellip
23
No diferegravencies en la retirada de categraveter per peritonitis
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
24
PQR i peritonitisldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
25
ADEQUACIOacute
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
26
ADEQUACIOacute PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
27
PQR i adequacioacute de diagravelisildquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
28
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
Peritonitishellip
22
PQR Control p
Peritonitis 055 056 078
Peritonitis per enterobacteries
128 116 09
Infeccioacute de quist
Risk factors for abdominal wall complications in peritoneal dialysis patients Del Peso G Bajo MA Costero O Hevia C Gil F Diacuteaz C Aguilera A Selgas R Perit Dial Int 2003 May-Jun23(3)249-54
Gegravermens diferents NO diferegravencies entre PQR i no PQR
Peritonitishellip
23
No diferegravencies en la retirada de categraveter per peritonitis
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
24
PQR i peritonitisldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
25
ADEQUACIOacute
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
26
ADEQUACIOacute PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
27
PQR i adequacioacute de diagravelisildquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
28
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
Peritonitishellip
23
No diferegravencies en la retirada de categraveter per peritonitis
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
24
PQR i peritonitisldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
25
ADEQUACIOacute
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
26
ADEQUACIOacute PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
27
PQR i adequacioacute de diagravelisildquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
28
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
24
PQR i peritonitisldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
25
ADEQUACIOacute
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
26
ADEQUACIOacute PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
27
PQR i adequacioacute de diagravelisildquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
28
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
25
ADEQUACIOacute
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
26
ADEQUACIOacute PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
27
PQR i adequacioacute de diagravelisildquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
28
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
26
ADEQUACIOacute PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
27
PQR i adequacioacute de diagravelisildquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
28
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
27
PQR i adequacioacute de diagravelisildquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
28
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
28
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
29
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
30
Fracagraves de tegravecnica 171 vs 206 471 problemes paret En els no PQR 371 peritonitis
SUPERVIVEgraveNCIA DE LA TEgraveCNICA
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
SUPERVIVEgraveNCIA DEL PACIENT
31
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
SUPERVIVEgraveNCIA DEL PACIENT
32
Peritoneal dialysis as the first-line renal replacement therapy in patients with autosomal dominant polycystic kidney disease Li L1 Szeto CC Kwan BC Chow KM Leung CB Kam-Tao Li P Am J Kidney Dis 2011 Jun57(6)903-7 doi 101053jajkd201101019 Epub 2011 Apr 2
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
33
PERITONEAL DIALYSIS CAN BE AN OPTION FOR DOMINANT POLYCYSTIC KIDNEY DISEASE AN OBSERVATIONAL STUDY Janeiro D Portoles J Mariacutea Tato A Lopez-Sanchez P Del Peso G Rivera M Castellano I Fernandez-Reyes MJ Perez-Gomez V Ortega M Martinez-Miguel P Felipe C Caparros G Ortiz A Selgas R Perit Dial Int 2014 Oct 7 pii pdi201400029
SUPERVIVEgraveNCIA DEL PACIENT
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
Causes de mortalitat PQR vs no PQRhellip
34
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
SUPERVIVEgraveNCIA DEL PACIENT
35
Kidney Int 2008 Oct74(7)946-51 doi 101038ki2008352 Epub 2008 Jul 23 Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis Kumar S1 Fan SL Raftery MJ Yaqoob MM
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
Supervivegravencia en funcioacute de la tegravecnicahellip
36
Renal replacement therapy for autosomal dominant polycystic kidney disease (ADPKD) in Europe prevalence and survival--an analysis of data from the ERA-EDTA Registry Spithoven EM Kramer A Meijer E Orskov B Wanner C Abad JM Aresteacute N de la Torre RA Caskey F Couchoud C Finne P Heaf J Hoitsma A de Meester J Pascual J Postorino M Ravani P Zurriaga O Jager KJ Gansevoort RT ERA-EDTA Registry EuroCYST Consortium WGIKD Nephrol Dial Transplant 2014 Sep29 Suppl 4iv15-25 doi 101093ndtgfu017
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
37
PQR i supervivegravencia de la tegravecnica io del pacientldquocheck-listrdquo
No hi ha cap diferegravencia amb la resta de causes drsquo insuficiegravencia renal
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
Conclusions (I)
La diagravelisi peritoneal en els pacients amb PQR com opcioacute de tractament renal substitutiu renal obteacute uns resultats no inferiors a lrsquohemodiagravelisi
Els resultats de la diagravelisi peritoneal en els
pacients amb PQR soacuten equiparables als obtinguts en els pacients amb altres causes drsquoinsuficiegravencia renal
38
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
Conclusions (II)
Caldragrave ser especialment curoacutes en el moment de la insercioacute del categraveter i de lrsquoexploracioacute de la paret abdominal (abans i durant)
Nomeacutes en aquells pacients amb gran megagravelies contraindicarem la diagravelisi peritoneal (sentit comuacute)
Valorar la DPA com opcioacute prioritagraveria en aquests pacients
39
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
Moltes gragravecies
Unitat de Diagravelisi Peritoneal Escalera 10 5ordf planta
mveracliniccat
dialpericliniccat
Jo mrsquohe adormit Espero que
vosaltres no
Top Related